PD‐L1 is a ligand‐protein produced by cancer cells that binds to PD‐1 on T lymphocytes, transmitting immunosuppressive signals that reduce the activation and proliferation of CD8+ T cells in lymph nodes. This evidence concerns the gene CD8A and cancer.